Font Size: a A A
Keyword [cardiac valve]
Result: 181 - 200 | Page: 10 of 10
181. Applications of The Visible Heart for cardiac valve repair and replacement devices
182. Inflammatory Regulatory Mechanism Of Mast Cell Involved In The Cardioprotective Effect Of Dexmedetomidine
183. Study On The Role Of MLR In Predicting Acute Kidney Injury After Cardiac Valve Surgery
184. Surgical Clinical Analysis Of Valvular Heart Disease With Giant Left Ventricle
185. Risk Factors Of Liver Function Injury After Cardiac Valve Surgery With Cardiopulmonary Bypass And Establishment Of Predictive Model
186. Risk Factors Of New-onset Atrial Fibrillation Early After Cardiac Valve Surgery
187. Analysis Of Early Curative Effect Of Cox-maze ? Radio Frequency Ablation In Patients Undergoing Cardiac Valve Replacement
188. Comparison Of Anesthetic Effect Of Sufentanil And Fentanyl In Heart Valve Surgery:A Meta-analysis
189. The Relationship Between Homocysteine And Acute Renal Injury After Cardiac Valve Replacement Surgery
190. Effect Of Dexmedetomidine On Postoperative Renal Function In Patients Undergoing Cardiac Valve Surgery Under Cardiopulmonary Bypass
191. Effect Of Preoperative High-density Lipoprotein On Acute Kidney Injury After Cardiac Valve Replacement Surgery
192. Comparative Study On Left Ventricular Function Before And After Cardiac Valve Surgery And Concomitant Coronary Artery Bypass Grafting
193. Effects Of Dexmedetomidine On Monocytes Pyroptosis In Peripheral Blood In Patients With Cardiac Valve Replacement Under Cardiopulmonary Bypass
194. Effect Of Residual Renal Function On Serum Klotho Protein And Cardiac Valve Calcification In Maintenance Hemodialysis Patients
195. Evaluation Of Fetal Cardiac Valves By Real-time 4D Volume Imaging With Electronic Matrix Probe
196. Relationship Between MHR And Cardiac Valve Calcification In Patients With Stage 3-5 Non-dialysis Chronic Kidney Disease
197. Analysis Of Cardiac Valve Calcification And Its Risk Factors In Patients With Chronic Kidney Disease
198. Risk Factors Of Cardiac Valve Calcification In Patients With Chronic Kidney Disease
199. The Analysis Of Risk Factors For Cardiac Valve Calcification In Patients With End-stage Renal Disease
200. Relationship Between Sclerostin (SOST) Level And Cardiac Valve Calcification In Middle-aged And Elderly Patients Undergoing Maintenance Hemodialysis(MHD)
  <<First  <Prev  Next>  Last>>  Jump to